Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7683-7688

  Kunwar, S ^a   Mohapatra, G ^a   Bollen, A ^a   Lamborn, K R ^a   Prados, M ^a   Feuerstein, B G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; DNA; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; AGING; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHROMOSOME 10P; CHROMOSOME 11P; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GLIOBLASTOMA; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; SURVIVAL RATE;

EID: 0035887448     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cancer statistics, 1990
2. Histopathology, classification, and grading of gliomas
3. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications
4. Highly anaplastic astrocytoma: A review of 357 patients treated between 1977 and 1989
5. Grading of astrocytomas. A simple and reproducible method
6. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience
7. Supratentorial low-grade astrocytomas in adults
8. Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation
9. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma
10. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas
11. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas
12. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: Amplified or not amplified? - An overview
13. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study
14. Gene amplification in human gliomas
15. Gene amplification in malignant human gliomas: Clinical and histopathologic aspects
16. The p53 gene and its role in human brain tumors
17. Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
18. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
19. Functional and molecular analyses of 10q deletions in human gliomas
20. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
21. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization
22. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade
23. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization
24. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization
25. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization
26. Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas
27. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization
28. Computer image analysis of comparative genomic hybridization
29. Long-term survival in malignant glioma. Prognostic factors
30. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma
31. Therapy and survival of adult patients with intracranial glioma in a defined population
32. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
33. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
34. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
35. Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization